The Food and Drug Administration announced on January 26, 2023, that the monoclonal antibody (mAbs) Evusheld™ is not currently authorized for preexposure prophylaxis against SARS-CoV-2 virus infection in the United States. The FDA based this action... READ →
Precision Vaccinations
/ January 28th, 2023Eliminating fake vaccine news with pharmacist, nurse, and physician review.
For more articles, try our search.